$25.26
-0.65-2.51%
At close: -
$25.26
0.000.00%
After Hours: 4:00 PM EDT
Beam Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Beam Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $-1.17 | $-1.16 | -0.86 % |
Q2 | 2024-08-06 | $-1.11 | $-1.14 | 2.63 % |
Q1 | 2024-05-07 | $-1.21 | $-1.42 | 14.8 % |
Q4 | 2024-02-27 | $1.73 | $-1.01 | 271.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $14.27M | $14.50M | -1.59 % |
Q2 | 2024-08-06 | $11.77M | $13.73M | -14.3 % |
Q1 | 2024-05-07 | $7.41M | $16.97M | -56.3 % |
Q4 | 2024-02-27 | $316.19M | $18.67M | 1593.6 % |
Beam Therapeutics (BEAM) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
The Actual EPS was $-1.17, which missed the estimate of $-1.16.
The Actual Revenue was $14.3M, which missed the estimate of $14.5M.
Browse earnings estimates, EPS, and revenue on all stocks.